Targeted anti-SGLT1 avian IgY antibodies as treatment of pre-diabetes, type 2 diabetes and gestational diabetes
AssigneeLay Sciences, Inc.
InventorUday Saxena
Life of this patent
Estimating the term…
Loading patent…
AssigneeLay Sciences, Inc.
InventorUday Saxena
Estimating the term…
Provided are methods for treating a disorder characterized by elevated blood glucose levels in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a hyperimmunized egg product obtained from an egg-producing animal, wherein the hyperimmunized egg product comprises a therapeutically effective amount of one or more IgY antibodies to an extracellular glucose binding domain of a sodium-glucose co-transporter SGLT. Also provided are hyperimmunized eggs and egg products produced by an animal that has been hyperimmunized with an antigen that contains an extracellular glucose binding domain of a sodium-glucose co-transporter SGLT or fraction thereof, and use of the hyperimmunized eggs or hyperimmunized egg products to reduce blood glucose levels in a subject, such as to treat type 2 diabetes. Methods or preparing the hyperimmunized eggs and hyperimmunized egg products are also provided.
An antibody characterized in that it binds to an extracellular glucose binding domain of a sodium—glucose co-transporter SGLT comprising a sequence selected from among:
A hyperimmunized egg produced by an avian that has been hyperimmunized with an antigen that comprises an extracellular glucose binding domain of a sodium—glucose co-transporter SGLT, wherein a level of antibodies to the antigen in the hyperimmunized egg is increased relative to an egg from an animal that has not been hyperimmunized, wherein the antigen comprises a sequence selected from among:
A formulation, comprising:
Dependencies are inferred from the claim text.